CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money?
Reported by Yahoo Finance · finance.yahoo.com · August 21, 2026
This year, the biotech stock has underperformed both the Nasdaq Biotechnology Index and the S&P 500.
What the tape says
What to watch: This report cites a concrete figure (8%) — compare it against the trailing trend before treating one data point as a turning point.
Market reaction today: $CRSP -4.08%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Yahoo Finance's reporting.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to Yahoo Finance. Wook of Wall Street is an independent research tool and is not affiliated with Yahoo Finance. Nothing here is financial advice or a recommendation — research and educational content only.